cabozantinib
exelixis
['urothelial carcinoma', 'cabozantinib', 'bladder', 'urothelial']
significant benefit not seen with maintenance cabozantinib in advanced urothelial carcinoma #asco22 #urology #urologist #urothelialcarcinoma #bladdercancer
Expert clinical analysis. Practice advice. Policy perspectives.